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Abstract
Healthcare Associated Infection (HCAI) caused by Multidrug-Resistant Acinetobacter
baumannii (MDRAB) is one of the important public health issues worldwide.
Carbapenem as the last line agents showed effectivity derivation for treating MDRAB
cases. Because there is a limited data about this in Indonesia, hence the HCAI
caused by MDRAB resistant to carbapenem case needs to be investigated. This was
a qualitative study using a case study approach. Purposive sampling technique was
chosen and applied to informants consisting of MDRAB patients and their family also
healthcare providers. Data were collected from in-depth interview, direct observations,
and documents review. An interactive model of Miles and Huberman was used as the
study’s analysis technique. We found that the MDRAB patients had favorably perceived
severity and self-efficacy. They found that their treatment was beneficial for them and
the existing barrier did not make them stop getting treatment. The patient’s family also
gave full support to get the treatment. Healthcare providers had a good experience and
understand their role in the hospital. The assembling of local antibiotics guideline was
not so easy due to different opinion among the doctors. We also found lack of funding
for surveillance of MDRAB and lack of awareness of it’s potential danger among the
majority informants. In conclusion, raising awareness of the HCAI caused by MDRAB
resistant to carbapenem is an urgent need. The commitment of healthcare providers
in following recommended guidelines is still needed some improvement. When all the
elements in the hospital reach the same understanding on this case, funding of the
surveillance will no longer become a big problem.
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Healthcare Associated Infection (HCAI) is known as one of major public health problem
worldwide and hundreds of millions of people are diagnosed with HCAI every year[1].
HCAI prevalence keeps increasing in both developed and developing countries [1, 2].
The prevalence of HCAI in Italy was increasing in the last decade from 4.6% to 6.8%, this
result also similar to other studies conducted in across Europe at the same period of
time [3]. Incidence densities of HCAI among developing countries are 10 until 20 times
higher compared to the US surveillance result [4].
HCAI term is made to fill the gap between Community Acquired Infection (CAI) and
Hospital Acquired Infection (HAI), where a patient with HCAI presenting different micro-
biological profiles compare to CAI and HAI, significantly [5]. The criteria are needed to
diagnose a patient with HCAI include a patient with infection problem, 48 hoursminimum
length of stay in a healthcare facility, and history of contact with any healthcare provider
in the last year [6, 7]. HCAI cause the longer patient length of stay, long-term disability,
higher hospital cost and patient’s spending on healthcare, unnecessary deaths, also
higher possibility of bacteria become MDR [1].
One of the major bacteria causing HCAI is Acinetobacter baumannii (AB), which also
become the common cause of HCAI in tropical countries compare to Europe and The
United States [8]. AB is a gram-negative bacteria that has a strong surviving capabil-
ity in the hospital environment [9]. Decades ago AB was also known as a commensal
pathogen with low pathogenicity, but in last decade AB becomes a high pathogen bac-
teria which can change themselves into multi-drug resistant bacteria (MDRAB) using
more than one mechanism [10, 11]. The high use of cephalosporin antibiotics also related
to the mechanism of AB become an MDRAB especially to carbapenem antibiotic due
to producing of carbapenemase. Moewardi hospital’s consumption of cephalosporin
antibiotics during 2017 was also high especially for the 3𝑟𝑑 generation of cephalosporins
[12]. Around 45.2% (n=104) of AB isolates were resistant to carbapenem antibiotic signif-
icantly, based on2017 study’s result conducted in the same hospital [13].
Based on Permenkes No.8 in 2015 (Indonesian Health Ministry regulations in antimi-
crobial resistance), all hospital in Indonesia have to apply regular monitoring in MDR
bacteria but so far only specific for Extended Spectrum Beta-Lactamase (ESBL) bacte-
ria and Methicillin-Resistant Staphylococcus aureus (MRSA) [14]. Although the effect of
the MDRAB case is huge moreover in developed countries, the emerging of MDRAB
in Indonesia also it’s resistance to carbapenem does not well recorded yet and get
attention as much as ESBL bacteria nor MRSA.
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2. Subject and Method
2.1. Study design, subject, and setting
This qualitative study aimed to investigate the cases of HCAI due to MDRAB resistant
to carbapenem in Moewardi hospital with case study approach. We were analyzing this
topic from patients and their family’s perception, the healthcare providers role, and their
collaboration to control MDRAB resistant to carbapenem cases, antimicrobial steward-
ship program and its application, also awareness of MDRAB resistant to carbapenem
cases and it’s surveillance. This study was granted full ethical approval by the medical
faculty of Universitas Sebelas Maret (UNS) ethical committee.
A purposive sampling technique was chosen and applied to the informants consist-
ing of MDRAB patients and their family, 4 doctors, 1 clinical microbiologist, 3 infection
control committees and 1 pharmacist. The diagnosis of the patient with MDRAB resistant
to carbapenem confirmed by the microbiology test result. Friedman criteria and medi-
cal record were used as guidelines to identified HCAI patients [13]. In-depth interviews
were conducted for 15-30 minutes for each informant, audio-recorded and transcribed.
Another resource used in this research was direct observations and documents review.
This study was conducted at Moewardi hospital, the main referral hospital in
Surakarta, Indonesia. This study was carried out between August and October 2017.
During this time, the hospital still focuses only on ESBL and MRSA.
2.2. Data collection technique
The data were collected from in-depth interviews. We listed questions based on Health
Belief Model theory to analyze the perception and behavior of the patient and their family
[15]. Another brief structured of questions were listed to investigate the cases. Direct
observation and document review were used to strengthen the data. Observations were
made to see the compliance of patients and or family, cleaning staff and healthcare
providers in preventing infection by washing hands and maintaining the cleanliness of
the hospital environment. Document reviewwas conducted to determine the prevalence
of HCAI due toMDRAB cases, AB cases in each hospital’s ward and its resistance pattern
on carbapenem also the use of cephalosporin and carbapenem in Moewardi hospital.
Data validity was confirmed by the triangulation technique and interactivemodel of Miles
and Huberman was used as the study’s analysis technique.
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3. Result
Wewere collecting interviews data from 11 informants. The authors found themain topics
of this study after collecting the data and analyzed it, those topics as follows: perceptions
of the MDRAB patients and their family in HCAI due to MDRAB case; the role and com-
petency of healthcare providers in hospital related to the case; the prudent antibiotic
use; surveillance of HCAI due to MDRAB and the awareness of HCAI caused by MDRAB
resistant to carbapenem.
3.1. Perceptions of the MDRAB patients and their family in HCAI
due to MDRAB case
All the patients already had treatment and stayed in another hospital before they were in
Moewardi hospital during the last three months, all of them also had bacterial infections
in that period of time. The patients and their family’s perception of severity or suscepti-
bility were positive. It meant that they understand if their condition is serious and need
an intensive caring. They understood that besides the main illness they also had an
infection problem and need immediate care.
The patients and their family’s perception of believing or self-efficacy were positive. It
meant that they believe their illness will heal as long as they follow what are the doctor
suggest them to do. When they were ill the first thing they would do were getting medi-
cation to the nearest healthcare center without thinking about alternative medication or
traditional one.
“We did not think about traditional medicine. Straight away looked for medical
attention, but we went to a primary health care center first...” the patient’s
family said.
Good service and care from the hospital made them more comfortable. They believe
they were in a good hand so their illness will heal.
A positive result also found in patient’s and family’s perception of benefit. They had an
experience before with another healthcare center that completely treated their illness,
so for this illness, they also had the same perception. One of the patients felt better after
a few days of treatment, meanwhile, the other patient was still in the same condition, but
his family had a big hope and positive attitude according to his condition.
The patients and family had positive result for perception barriers, meant that they
kept looking for medical attention from the healthcare center even if it needs long hours
driving. Usually, they choose a hospital who accepts Indonesian national insurance so
DOI 10.18502/kls.v4i12.4181 Page 258
ICO-HELICS
they would get free medication and would save some budget. All the patients needed
to be transferred to the bigger hospital and it went well without any problem because
they got help and support from their family.
The patients and family had a positive result for a perception of motivation and family
support. The patient’s family always next to them when they were in the hospital. The
patient’s spouse or children were the common family members who accompany them
in the hospital, but sometimes another family member such as sister, brother, daughter
or son-in-law as well. When it’s time to take an oral medication in the hospital, the family
playing a big role to give the medication to the patient (except for the patient in the
intensive care unit).
“His wife or his kids. When they need to work, they go to work first and when
it’s time to drink the medicine, they go back to give it to the patient.” said the
patient’s family.
While the patients were at home their family usually help the patients to take their oral
medication and were with them when they need to go to the hospital for checking up
their condition. Even the patients and family member only knew the general condition
of the illness they still motivated to have a better condition after their treatment finish.
3.2. The role and competency of medics and paramedics in the
hospital related to HCAI caused by MDRAB case
The healthcare providers’s work experience was between 6 until 11 years in Moewardi
hospital. They joined a lot of courses or workshops during those years about nosoco-
mial and community infections, also the prudent use of antibiotics. They also already
joined in a national committee for bacterial infections and resistance, called Komite
Penanggulangan Resistensi Antibiotik (KPRA) since 2010. The KPRA consist of doctors
from different specialties, pharmacists, nurses, and other paramedics. As the member
of KPRA, they have to follow the national guideline and have an obligation to attend a
meeting periodically.
Under the KPRA, there is an antimicrobial stewardship team called Penjagaan dan
Pengendalian Infeksi (PPI). This team also consists of various healthcare providers. They
do the surveillance about general bacterial counts in hospital, monitoring environmental
contaminants and surveillance about hand hygiene among healthcare providers. Among
all healthcare providers, they already involved in KPRA, or at least only as PPImember (1
doctor). When there were cases of nosocomial infections or any other multiple infections
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in patient occur, the doctor immediately consults to the PPI team, but most of them
straight away contacted the microbiologist to decide suitable antibiotic.
About 75% doctors recognized well the infections caused by Acinetobacter bauman-
nii and it’s resistance to some groups of antibiotics that lead these bacteria to become
MDRAB, but 100% doctors did not recognize well the term of HCAI, since this term in
Indonesia still really rare to discuss. Only the microbiologist aware enough about the
MDRAB resistant to carbapenem, but the other informants still consider this as the usual
or regular case only.
“...the awareness to Acinetobacter cases...is not good enough,...still think that
it’s just a common case...” internist said.
3.3. The prudent antibiotic use
Based on microbiologist statement, the ideal way to make antibiotics guideline is
through making a report about bacterial resistance pattern found in a local healthcare
facility. Moewardi hospital was giving this responsibility to the microbiology depart-
ment. Microbiology department made the report for Moewardi hospital yearly and
made antibiotics guideline based on that report. This antibiotics guideline were then
being distributed to all wards in Moewardi hospital. Problems came when applying this
guideline to the patients because different doctors had different opinion.
Moewardi hospital also made a regulation about the use of empirical and prophylaxis
antibiotics. When the use of those antibiotics was more than the recommendation then
the pharmacist would inform “stop order” for those particular antibiotics.
“As a pharmacist, we also joined the KPRA team, become part of this com-
mittee. For antibiotics, we already had rules and regulations about the use of
empirical and prophylaxis antibiotics. We also had an automatic stop order
mechanism for empirical antibiotics that had been used more than three
times.” the pharmacist said.
Pharmacist already had teams in almost every wards and intensive care unit (ICU) to
record the antibiotics use and make an annual report about it. They also make some
qualitative and quantitative study about the prudent antibiotic use, but all the studies
only for ICUbecause of lack of resources. The result of those studieswould be presented
and reported on national scale annually and some data reported monthly. The target of
prudent antibiotic use is 100%, but after the evaluation results came, is showed that
Moewardi hospital did not yet achieve the 100% target. Few times Moewardi hospital
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was out of stock of some antibiotics, then usually pharmacist would contact the doctor
and talk about the alternative antibiotics.
3.4. The awareness of HCAI caused by MDRAB resistant to car-
bapenem and it’s surveillance
Almost all informants did not consider HCAI case caused by MDRAB resistant to car-
bapenem as an urgent case, only the microbiologist did. Unlike the other case of bac-
terial infections such as Extended Spectrum of Beta-Lactamase (ESBL) and Methicillin-
Resistant Staphylococcus Aureus (MRSA) bacterias, that being regularly surveyed, the
MDRAB case completely did not have distinct surveillance.
PPI and the doctor in charge usually labeled a patient with an infection when it was
already confirmed, or potentially infectious when it was still under investigation.When an
infectious patient came, Moewardi hospital already had a special room for them, such as
for airborne infection like MDR tuberculosis they prepared an isolated room. Moewardi
hospital also has an isolated roomwith negative or positive pressure for certain infection
cases. When the number of infectious patients was more than the number of isolated
room, then the hospital makes an isolated chamber inside the available ward, usually,
those chambers are located in the corner and only separated by a curtain from the other
patients (except for VIP patient).
“It for sure become a big source of cross-infection among the patients”, said
the internist doctor.
Based on the report of microbiology department of Moewardi hospital in 2016, ABwas
included in 5 biggest gram-negative bacteria (4𝑡ℎ) found in Moewardi hospital, and gen-
erally was in the yellow zone towards carbapenem antibiotic (only 40-<70% sensitive).
AB that found in Pediatric and Neonatal Intensive Care Unit (PICU-NICU) were also in
the yellow zone towards carbapenem antibiotic (doripenem and meropenem) but lower
rate compared to the AB found in other wards. But towards one of carbapenem group
antibiotic, imipenem, AB was in the red zone (<40% sensitive). While in the pediatrics
ward, ABwas in the red zone towards imipenem andmeropenem, and in the yellow zone
towards doripenem. In the neonatal ward, AB was also in the yellow zone towards car-
bapenemantibiotic. The AB found in internal medicinewardwere in yellow zone towards
doripenem and meropenem, but towards imipenem, AB was in the red zone. The worst
result found in the surgery ward, where all of the AB was in the red zone towards the
carbapenem antibiotics. Unlike the surgery ward, the result from pulmonology ward for
all AB was still in the green zone.
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4. Discussion
The MDRAB patients in Moewardi hospital had favorably perceived severity and self-
efficacy. They found that their treatment was beneficial for them and the existing barrier
did not make them stop in getting treatment. Problems in Moewardi hospital came when
doctor applying antibiotic guideline to the patients because each doctor has a different
opinion. Some doctors do not follow hospital guidelines and formularies. The doctor
from internal medicine department for example, firstly they gave an empirical antibiotic.
When the empirical antibiotic work then they continue to use it, if it did not work then
they would increase the dosage first. After the culture and sensitivity test finished they
did not straight away follow the antibiotics suggestion written by themicrobiologist. Only
when it still did not work then they changed the antibiotic according to themicrobiologist
suggestion. If there were more than one suggestion they decided to use antibiotics from
the “lower” group first. The consultant doctor of ICU chose to strictly follow theMoewardi
hospital’s guideline and the suggestion made by the microbiologist.
When the use of antibiotics is more than the recommended rules, the pharmacist will
inform the ”stop order” for certain antibiotics. In this case, the role of pharmacists is also
needed to talk about alternative antibiotics. Restricting the prescription of antimicrobial
agents based on the hospital’s formulary is also a policy made by Moewardi hospital
to prevent antimicrobial resistance. Restrictions on the use of carbapenem in the for-
mulary such as carbapenem use only for third-line therapy for ESBL-producing bacterial
infections, used for a maximum of 7 days per case and used when carbapenem is the
only antibiotic that still sensitive to the bacteria based on culture results. Restricting the
prescription of antimicrobial agents is important, but it is difficult to decidewhich regimen
is the best to treat the patients for empirical therapy [16].
Cheon et al. reported that implementing an antimicrobial management program for
the use of carbapenem has decreased the level of nosocomial MDRAB’s incidence [17].
Another result from this antimicrobial management program was the increased use of
piperacillin/ tazobactam and ciprofloxacin because this antibiotic was chosen to be an
alternative to carbapenems. While in Moewardi hospital when MDRAB resistant to car-
bapenem, the alternatives antibiotic were amikacin that still in the green zone [18]. In
other studies conducted by Huang et al. suggested that early discontinuation of car-
bapenem could be an effective measure in antibiotic stewardship for controlling MDRAB
spreading [19].
Moewardi hospital has been equipped with isolation rooms for certain infection case
also rooms with negative or positive pressure for special infection cases. The standards
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of isolation rooms are: should have tight-fitting doors, glass partitions for both negative
and pressure (for source isolation) and positive-pressure (for protective isolation) ventila-
tion [20]. But these standards could not be applied when all the isolation rooms full and
the patients outnumbered. This is problematic because the public hospital trapped in
some rules and regulations. They are expected to receive all the incoming patients, but
no suitable room available, meanwhile they do not have enough budget to build more
isolation rooms.
HCAI surveillance case caused byMDRAB resistant to carbapenemneeds to be a hos-
pital priority, in addition to HCAI priority due to ESBL and MRSA. Carbapenem-resistant
Acinetobacter baumannii (CRAB) has been shown to be a serious challenge globally so
that it requires full-scale national surveillance of CRAB [21]. Based on the previous study
conducted in Moewardi hospital for HCAI, all CRAB were MDRAB [13]. When the hospital
run surveillance for HCAI due to MDRAB it will reduce it’s prevalence and incidence
also other negative impacts related to this case. The surveillance’s cost is very small
compared to the burden of this case, hencewe hope the government will start to arrange
surveillance for it.
The major cause of antibiotic resistance is irrational antibiotic use, including CRAB
cases in HCAI. Differences in MDRAB resistance levels to carbapenem in each ward
in Moewardi hospital describes the compliance of antibiotic prescribing by a doctor are
still need to be improved. AB foundmostly in pulmonology ward and all carbapenem still
sensitive to combat AB (green zone), but in the surgery ward, all the carbapenemwere in
the red zone. This phenomenon is very interesting and a deeper investigation is needed.
Based on the previous study the commitment of the doctors in following recommended
guidelines is still need some improvement [22]. Furthermore, to elucidate this finding,
the qualitative study of the prudent use of antibiotics in these two wards using Giessen
algorithm is needed to see whether this problem occurs because of irrational antibiotics
use or not. As the only prior qualitative study in Indonesia about HCAI caused byMDRAB
resistant to carbapenem, this study can be based on the following research.
5. Conclusion
Rising awareness of the HCAI caused by MDRAB resistant to carbapenem is an urgent
need. The commitment of healthcare providers in following the recommended guide-
lines still needs some improvement. When all elements in the hospital reach the same
understanding on this case, the funding of the surveillance will no longer become a big
problem.
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